SCHEMBL11943170

SCHEMBL11943170

COc1ccc(Cl)cc1NC(=O)N1CCN(c2cnn(-c3ccccc3)c(=O)c2N2CCN(C)CC2)CC1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RBP4 P02753 7/20 0.64
▸ MAPK1 P28482 3/20 0.54
▸ HTR1A P08908 5/20 0.52
▸ HTR1D P28221 5/20 0.52
▸ HTR1B P28222 5/20 0.52
▸ DCTPP1 Q9H773 1/20 0.51
▸ HTR2A P28223 3/20 0.51
▸ HTR2C P28335 3/20 0.51
▸ HTR6 P50406 3/20 0.51
▸ MAPT P10636 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HTR7 P34969 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13329640 0.91 HTR1A (0.53) RBP4HTR1AHTR1DHTR1BDCTPP1
SCHEMBL16690825 0.79 RBP4 (1.00) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL4306582 0.78 MAPT (0.73) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL13304705 0.78 ALDH1A1 (0.47) RBP4MAPK1DCTPP1MAPTKDM4E
SCHEMBL16690804 0.77 RBP4 (1.00) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL11943276 0.76 MAPT (0.61) MAPK1HTR1AHTR1DHTR1BDCTPP1
SCHEMBL11943260 0.75 KMT2A (0.50) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL16690848 0.74 RBP4 (0.83) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL4301167 0.74 MAPT (0.67) RBP4MAPK1HTR1AHTR1DHTR1B
SCHEMBL11943255 0.74 KMT2A (0.53) DCTPP1MAPTKDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA RBP4 4125/4885MAPK1 1289/4885HTR1A 4010/4885
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS DPM1, GMPS, MAN2A1 RBP4 4580/4885MAPK1 775/4885HTR1A 4468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback